References
1. Braunwald EB, ed. Heart disease : A textbook of cardiovascular medicine 2001. 6th edth ed. Philadelphia: WB Saunders; 1114–1231.
3. White HD. Thrombolytic therapy and equivalence trials. J Am Coll Cardiol 1998. 31494–496.
4. Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators : Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction : The ASSENT-2 double-blind randomised trial : Assessment of the Safety and Efficacy of a New Thrombolytic Investigators. Lancet 1999. 354716–722.
5. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Smith SC Jr, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction : a report of the ACC/AHA Task Force on Practice Guidelines. J Am Coll Cardiol 2000. 36970–1062.
6. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Theroux P, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002 : a report of the ACC/AHA Task Force on Practice Guidelines. Circulation 2002. 1061893–1900.
7. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syncrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med 1998. 3381488–1497.
8. Inhibition of platelet glycoprotein IIb/IIIa receptor with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina : Receptor Suppression Using Integrilin Therapy. N Engl J Med 1998. 339436–443.
9. ISIS-2(Second International Study of Infarct Survival) Colaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,817 cases of suspected acute myocardial infarction. Lancet 1988. 2349.
10. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel vs. aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996. 3481329–1339.
11. The CURE investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST segment elevation. N Engl J Med 2001. 10952–58.
12. Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S, et al. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation : a meta-analysis. Lancet 2000. 3551936–1942.
13. AHA/ACC/ACP-ASIM guidelines for the management of the patients with chronic stable angina : Executive Summary and Recommendations. Circulation 1999. 992829–2848.
14. Opie LH. First line drugs in chronic stable effort angina-the case for newer, longer-acting calcium channel blocking agents. J Am Coll Cardiol 2000. 361967–1971.
15. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of an ACE inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 2000. 342145–153.
16. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Williams SV, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina : a report of the ACC/AHA Task Force on Practice Guidelines. Circulation 2003. 107149–158.
17. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998. 352837–853.
18. Executive Summary of the third report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults(Adult Treatment Panel III). JAMA 2001. 2852486–2497.